The Medacta International AMIStem-P Post-Marketing Surveillance Study (NCT04997005) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
The Medacta International AMIStem-P Post-Marketing Surveillance Study
France550 participantsStarted 2019-04-26
Plain-language summary
This is a Post-Market Surveillance study of AMIStem-P femoral stem prosthesis
Who can participate
Age range18 Years – 85 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with a disease (primary coxarthrosis, inflammatory arthritis of the hip, necrosis of the femoral head, etc.) requiring a total hip replacement
* Patient eligible to receive an uncemented AMIStem-P femoral stem
* Patient agreeing to comply with the study requirements
* Patient willing to provide written informed consent
* Patient affiliated to a social security system
* Patients between 18 and 85 years old
Exclusion Criteria:
* Participation in biomedical research
* Patients younger than 18 years old
* Vulnerable adult patients according to article L1121-6 of the French Public Health Code
* Pregnant or breastfeeding women
* Patients unable to provide written informed consent